iSpecimen Inc. (NASDAQ:ISPC) went up by 5.47% from its latest closing price compared to the recent 1-year high of $28.98. The company’s stock price has collected -9.06% of loss in the last five trading sessions. Press Release reported on 01/04/22 that iSpecimen to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022
Is It Worth Investing in iSpecimen Inc. (NASDAQ :ISPC) Right Now?
ISPC currently public float of 6.01M and currently shorts hold a 9.17% ratio of that float. Today, the average trading volume of ISPC was 5.98M shares.
ISPC’s Market Performance
ISPC stocks went down by -9.06% for the week, with a monthly drop of -50.87% and a quarterly performance of 34.99%. The volatility ratio for the week stands at 13.97% while the volatility levels for the past 30 days are set at 17.95% for iSpecimen Inc.. The simple moving average for the period of the last 20 days is -28.94% for ISPC stocks with a simple moving average of -2.32% for the last 200 days.
ISPC Trading at -25.67% from the 50-Day Moving Average
After a stumble in the market that brought ISPC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.71% of loss for the given period.
Volatility was left at 17.95%, however, over the last 30 days, the volatility rate increased by 13.97%, as shares sank -46.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.55% upper at present.
During the last 5 trading sessions, ISPC fell by -9.06%, in comparison to the 20-day moving average, which settled at $10.00. In addition, iSpecimen Inc. saw -6.15% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ISPC starting from Curley Tracy, who purchase 2,000 shares at the price of $5.12 back on Nov 17. After this action, Curley Tracy now owns 10,000 shares of iSpecimen Inc., valued at $10,240 using the latest closing price.
Ross Andrew L., the Director of iSpecimen Inc., purchase 1,000 shares at $5.19 during a trade that took place back on Nov 16, which means that Ross Andrew L. is holding 1,314,524 shares at $5,190 based on the most recent closing price.
Stock Fundamentals for ISPC
Current profitability levels for the company are sitting at:
- -29.40 for the present operating margin
- +56.19 for the gross margin
The net margin for iSpecimen Inc. stands at -56.84. Equity return is now at value 95.20, with -69.10 for asset returns.
The receivables turnover for the company is 4.36 and the total asset turnover is 1.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.16.